| The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench MC Bacon, V Von Wyl, C Alden, G Sharp, E Robison, N Hessol, S Gange, ... Clinical and Vaccine Immunology 12 (9), 1013-1019, 2005 | 573 | 2005 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 475 | 2011 |
| Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and … RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ... The Lancet infectious diseases 9 (7), 409-417, 2009 | 322 | 2009 |
| Mortality of HIV-infected patients starting potent antiretroviral therapy: comparison with the general population in nine industrialized countries Antiretroviral Therapy Cohort Collaboration International journal of epidemiology 38 (6), 1624-1633, 2009 | 256 | 2009 |
| Estimating the basic reproductive number from viral sequence data T Stadler, R Kouyos, V von Wyl, S Yerly, J Böni, P Bürgisser, T Klimkait, ... Molecular biology and evolution 29 (1), 347-357, 2012 | 235 | 2012 |
| Molecular epidemiology reveals long-term changes in HIV type 1 subtype B transmission in Switzerland RD Kouyos, V Von Wyl, S Yerly, J Böni, P Taffé, C Shah, P Börgisser, ... The Journal of infectious diseases 201 (10), 1488-1497, 2010 | 202 | 2010 |
| Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey S Yerly, V von Wyl, B Ledergerber, J Böni, J Schüpbach, P Bürgisser, ... Aids 21 (16), 2223-2229, 2007 | 180 | 2007 |
| Ambiguous nucleotide calls from population-based sequencing of HIV-1 are a marker for viral diversity and the age of infection RD Kouyos, V von Wyl, S Yerly, J Böni, P Rieder, B Joos, P Taffé, C Shah, ... Clinical infectious diseases 52 (4), 532-539, 2011 | 171 | 2011 |
| Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types V Von Wyl, S Yerly, J Böni, P Bürgisser, T Klimkait, M Battegay, H Furrer, ... Archives of internal medicine 167 (16), 1782-1790, 2007 | 169 | 2007 |
| The disease burden of multiple sclerosis from the individual and population perspective: which symptoms matter most? L Barin, A Salmen, G Disanto, H Babačić, P Calabrese, A Chan, ... Multiple sclerosis and related disorders 25, 112-121, 2018 | 165 | 2018 |
| Phylogenetic approach reveals that virus genotype largely determines HIV set-point viral load S Alizon, V Von Wyl, T Stadler, RD Kouyos, S Yerly, B Hirschel, J Böni, ... PLoS pathogens 6 (9), e1001123, 2010 | 146 | 2010 |
| Complement lysis activity in autologous plasma is associated with lower viral loads during the acute phase of HIV-1 infection M Huber, M Fischer, B Misselwitz, A Manrique, H Kuster, B Niederöst, ... PLoS medicine 3 (11), e441, 2006 | 141 | 2006 |
| Inferring epidemic contact structure from phylogenetic trees GE Leventhal, R Kouyos, T Stadler, V Von Wyl, S Yerly, J Böni, C Cellerai, ... PLoS computational biology 8 (3), e1002413, 2012 | 126 | 2012 |
| Drivers of acceptance of COVID-19 proximity tracing apps in Switzerland: panel survey analysis V von Wyl, M Höglinger, C Sieber, M Kaufmann, A Moser, M Serra-Burriel, ... JMIR public health and surveillance 7 (1), e25701, 2021 | 125* | 2021 |
| The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection S Yerly, T Junier, A Gayet-Ageron, EB El Amari, V von Wyl, HF Günthard, ... Aids 23 (11), 1415-1423, 2009 | 120 | 2009 |
| Early evidence of effectiveness of digital contact tracing for SARS-CoV-2 in Switzerland M Salathé, CL Althaus, N Anderegg, D Antonioli, T Ballauz, B Edouard, ... medRxiv, 2020.09. 07.20189274, 2020 | 118 | 2020 |
| Profound depletion of HIV-1 transcription in patients initiating antiretroviral therapy during acute infection A Schmid, S Gianella, V von Wyl, KJ Metzner, AU Scherrer, B Niederöst, ... PloS one 5 (10), e13310, 2010 | 113 | 2010 |
| Effect of early antiretroviral therapy during primary HIV-1 infection on cell-associated HIV-1 DNA and plasma HIV-1 RNA Swiss HIV Cohort Study, S Gianella, V von Wyl, M Fischer, B Niederoest, ... Antiviral therapy 16 (4), 535-545, 2011 | 107 | 2011 |
| Treatment-naive individuals are the major source of transmitted HIV-1 drug resistance in men who have sex with men in the Swiss HIV Cohort Study SM Drescher, V von Wyl, WL Yang, J Böni, S Yerly, C Shah, V Aubert, ... Clinical Infectious Diseases 58 (2), 285-294, 2014 | 99 | 2014 |
| Digital health and the COVID-19 epidemic: an assessment framework for apps from an epidemiological and legal perspective KN Vokinger, V Nittas, CM Witt, SI Fabrikant, V Von Wyl Swiss medical weekly 150, w20282, 2020 | 95 | 2020 |
Huldrych F. GünthardProfessor for Infectious Diseases, University Hospital ZurichEmail verificata su usz.ch
